피부암 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global skin cancer treatment market size is expected to reach USD 30.50 Billion in 2034 from USD 15.18 Billion in 2025, growing at a CAGR of 8.06 during 2026-2034.This market is experiencing significant growth due to the increasing incidence of skin cancer worldwide and the growing awareness of early diagnosis and treatment. Skin cancer treatments include surgical procedures, radiation therapy, chemotherapy, and targeted therapies. The rising exposure to ultraviolet radiation and changing lifestyle patterns are key factors contributing to the increasing prevalence of skin cancer. Additionally, advancements in medical technology are improving treatment outcomes and driving market growth.

Growth drivers include the development of innovative therapies such as immunotherapy and targeted treatments that offer improved efficacy and reduced side effects. The increasing availability of advanced diagnostic tools is enabling early detection, which enhances treatment success rates. Government initiatives and awareness campaigns are also encouraging individuals to seek timely medical attention. Furthermore, the expansion of healthcare infrastructure and access to specialized treatments are supporting market growth.

Looking ahead, the skin cancer treatment market is expected to witness continuous advancements in treatment technologies and personalized medicine. Companies are likely to focus on developing more effective and less invasive treatment options. The integration of artificial intelligence and data analytics in diagnosis and treatment planning will further improve outcomes. As awareness and healthcare access continue to improve, the demand for skin cancer treatments is anticipated to grow steadily.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Disease Indication

• Melanoma
• Nonmelanoma

By Therapy

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Radiation Therapy

By Distribution Channel

• Hospitals Pharmacy
• Retail Pharmacy
• Others

COMPANIES PROFILED

• Merck & Co., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Amgen Inc., GlaxoSmithKline plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SKIN CANCER TREATMENT MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease Indication
• 4.2. Melanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nonmelanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SKIN CANCER TREATMENT MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Targeted Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SKIN CANCER TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospitals Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SKIN CANCER TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Disease Indication
  • 7.2.2 By Therapy
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Disease Indication
  • 7.3.2 By Therapy
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Disease Indication
  • 7.4.2 By Therapy
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Disease Indication
  • 7.5.2 By Therapy
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Disease Indication
  • 7.6.2 By Therapy
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SKIN CANCER TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Merck & Co
  • 9.2.2 Bristol-Myers Squibb Company
  • 9.2.3 Novartis AG
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Amgen Inc
  • 9.2.6 GlaxoSmithKline Plc
  • 9.2.7 Pfizer Inc
  • 9.2.8 Sun Pharmaceutical Industries Ltd
  • 9.2.9 Regeneron PharmaceuticalsInc